Previous research has shown that administering recombinant human Osm to mice before the initiation of ischemia/reperfusion can improve prognosis in mouse models of ischemic stroke by activating the JAK2/STAT3 signaling pathway in neurons (Guo et al., 2015). The gene discussed is OSM; the disease is ischemia.